Movatterモバイル変換


[0]ホーム

URL:


US3906950A - Inhaling device for powdered medicaments - Google Patents

Inhaling device for powdered medicaments
Download PDF

Info

Publication number
US3906950A
US3906950AUS457270AUS45727074AUS3906950AUS 3906950 AUS3906950 AUS 3906950AUS 457270 AUS457270 AUS 457270AUS 45727074 AUS45727074 AUS 45727074AUS 3906950 AUS3906950 AUS 3906950A
Authority
US
United States
Prior art keywords
inhaler
pair
pump
piece
capsule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US457270A
Inventor
Salvatore Cocozza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ISF SpA
Original Assignee
ISF SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT2257673Aexternal-prioritypatent/IT986056B/en
Priority claimed from IT2569873Aexternal-prioritypatent/IT1045851B/en
Application filed by ISF SpAfiledCriticalISF SpA
Application grantedgrantedCritical
Publication of US3906950ApublicationCriticalpatent/US3906950A/en
Anticipated expirationlegal-statusCritical
Expired - Lifetimelegal-statusCriticalCurrent

Links

Images

Classifications

Definitions

Landscapes

Abstract

An inhaling device for medicinal powders comprising a pump and an inhaler wherein the inhaler has a cavity formed by the interconnection of two compartments for holding a puncturable capsule containing a medicinal powder. Two sliding needles acting against the action of return springs pierce the capsule. In a preferred embodiment, the lower body portion of the inhaler is attached to the pump when in use and may be stored in ''''at rest'''' position when the inhaler is inverted into the pump.

Description

tinited States @ocozza 1 INHALING DEVICE FOR POWDERED MEDICAMENTS [75] lnventor: Salvatore Cocozza, Milan, Italy [73} Assignee: I.S.F. S.p.A., Milan, ltaly [22] Filed: Apr. 2, 1974 [21] Appl. No.: 457,270
[30] Foreign Application Priority Data Apr. 4, 1973 Italy 22576/73 June 22, 1973 Italy; 25698/73 [52] US. Cl. 128/266; 128/206 [51] Int. Cl. A61M 13/00; A61M 15/08 [58] Field of Search 128/266, 206, 208, 194, 128/265 [56] References Cited UNITED STATES PATENTS 2,307,986 l/1943 Bolt et al. 128/266 so ,2 20* y 2,517,482 8/1950 Hall 128/206 2,519,555 8/1950 128/266 2,581,182 l/1952 128/206 2,946,332 7/1960 Sacks 128/266 3507277 4/1970 Altounyan et al 128/208 3,669,113 6/1972 Altounyan et a1. 128/266 Primary Examiner-Aldrich F. Medbery Attorney, Agent, or Firm-Depaoli & OBrien [57] ABSTRACT An inhaling device for medicinal powders comprising a pump and an inhaler wherein the inhaler has a cavity formed by the interconnection of two-compartments for holding a puncturable capsule containing a medici nal powder. Two sliding needles acting against the action of return springs pierce the capsule. In a preferred embodiment, the lower body portion of the inhaler is attached to the pump when in use and may be stored in at rest position when the inhaler is inverted into the pump.
22 Claims, 6 Drawing Figures r L 56o US Patent Sept. 23,1975 Sh6t 1 01 2 3,906,950
US mm Sept. 23,1975 Sheet 2' 0f 2 3,9,%
INHALING DEVICE FOR POWDERED MEDICAMENTS BACKGROUND OF THE INVENTION 1. Field of the Invention The invention relates to an inhaler for the administration of medicinal powders. More particularly, the inhaler relates to a traditional pump and an inhaler body having means for piercing a stored capsule containing medicinal powder.
2. Description of the Prior Art Inhalers are already known utilizing an elastic pump and a needle piercing a capsule which contains a me' dicinal substance; generally their working is not completely satisfactory as a result of rather complicated construction and cumbersome dimensions. In the in haler of the present invention, the above mentioned inconveniences have been practically eliminated, so that the inhaler is easily and quickly constructed and of reduced dimensions.
SUMMARY OF THE INVENTION It is the object of this invention to providean inhaler having simplified construction and reduced dimensions for use in combination with a conventional pump as an inhaling device for supplying medicinal powders to a body cavity.
It is another object to provide an inhaler having means for partial storage within the pump therefor.
It is an additional object to provide an inhaler having a means wheel to facilitate locking engagement with the pump.
It is a further object to provide an inhaler having a plurality of slidable alignment means. I
It is also an object to provide an inhaler having a spring-biased means for penetrating each end of a capsule stored therewithin.
In satisfaction of these objects and in accordance with the spirit of this invention, the inhaler contains a cavity-penetrating element. at one end thereof, through which air-entrained powder is forced out into a body cavity. a central element with an inside cavity for locating a capsule of medicinal powder therewithin. a pair of piercing devices for the endwise perforation of the capsule, and a base element having a polished surface interrupted by a ratchet wheel for connection with the pump. In more detail, the central element ofthe inhaler body is relatively fixed and formed by two components which are connected to each other, for example, by threading, bayonet insertion, and similar techniques. These components define a cavity therewithin, for placement of the capsule, and are slidably attached to a pair of relatively movable elements which hold piercing needles and which telescopically slide inside the two above-mentioned capsule holder components against the action of a pair of return springs.
The base element of the inhaler is so shaped that when the device is not in use, the inhaler body may be inverted into the pump, therby resulting in a noticeable reduction in overall size and a pleasant compact aspect of the whole which is aesthetically and practically favorable.
The inhaling device is adapted for delivering powdered substances in aerated form from a pierced capsule and comprises a pump and an inhaler, the inhaler comprising a relatively fixed central element formed by two connectable components and defining a cavity for reception of the capsule. and a pair of relatively moveable needle holder elements telescopically slidablc within the connectable components against the action of a pair of return springs. The components may be connected by screw means, a bayonet clutch means. or the like. Each of the pair of needle holder elements comprises a capsule-piercing needle. Each of the components is attached to a sleeve having an interior shoulder and each of the pair of needle holder elements has an outwardly disposed shoulder which is capable of reciprocating between a rest position against one of the interior shoulders and a ncedle-piercing position against one of the connectable components. The inhaler also comprises a nose piece and a pump piece and one of the pair of holder elements is locked by friction to the noscpiecc and the other of the pair of needle holder elements may be locked against the piece by mi cro-ribs having saw teeth.
BRIEF DESCRIPTION OF THE DRAWINGS The inhaler which constitutes the present invention is shown in the accompanying drawings of the preferred embodiment in which:
FIG. 1 represents a side elevation of the assembled inhaling device comprising the inhaler inserted in a pump in operative condition.
FIG. 2 is a side elevation similar to FIG. I with the inhaler inverted in the pump to reduce the size of the device while partially stored therewithin.
FIG. 3 is a longitudinal section through the inhaler while in uncompressed condition.
FIG. 4 is a longitudinal section of the inhaler. similar to FIG. 3 but with the inhaler in a compressed condition, while in operative combination with a pump.
FIG. 5 is a cross-section taken alonglines 55 of FIG. 3, and
FIG. 6 is a side elevation of the noseward component of the cavity-forming element.
DESCRIPTION OF THE PREFERRED EMBODIMENT Referring to the drawings. theinhaler 8 of this invention is employed in combination with aconventional pump 100 and comprises acentral storage unit 10 having a central cavity defined bywalls 13 within which a medicinal powder-container capsule 15 is inserted as needed by unscrewing a pair ofcompartments 20, 30. A pair ofstop sleeves 60, 70 are non-slidably attached to theunit 10 and are outside of and in sliding relation to a pair ofneedle holders 40, containing a pair of capsule-puncturingneedles 41, 51. The pair ofstop sleeves 60, is also within and in sliding relation to a pair of end pieces, the nose piece and thepump piece 90, to which theholders 40, 50 are rigidly attached. Theholders 40, 50 are biased away from the central cavity by a pair ofsprings 25, 35.
Coaxially disposed throughout the entire inhaler of this invention are a series of central holes for passage of air which enters the inhaler from the pump throughbase opening 98 andair passage 58, passes through the fourair passages 59 shown in FIG. 5 tocentral hole 32 aroundpump needle 51, enters and passes through thepunctured capsule 15 while entraining medicinal powder therefrom. travels pastnose needle 41 throughcentral hole 22, passes through the fourair passages 49 intoswirl compartment 83, and exits from the inhaler throughdischarge hole 81 innosepiece 80.
The unit is formed by screwably connecting the nose compartment and thebase compartment 30. Thecompartments 20, have coaxially disposedcentral holes 22, 32, annularly disposedspring wells 24, 34 which open away from thecapsule 15, outer cylindrical recesses withsurfaces 23, 33, and connectingscrew threads 29, 39 by means of which thecompartments 20, 30 are connected.Nose return spring 25 is seated within spring well 24, and pump return spring is seated within spring well 34.
Nose needle holder 40 and pump needle holder have somewhat l-l-shaped cross sections and comprise. respectively, annularfixed ends 46, 56 and annularsliding ends 47, 57 which rest against thesprings 25, 35 within thespring wells 24, 34, as shown in FIG. 4. Theholders 40, 50 also comprise fourair passages 49, 59 which are separated by four radially spaced longitudinally disposed ribs, ribs 54 only being identified in FIG. 5. Each set ofribs 44, 54 supports a central portion containing a central needle recess which opens only toward the central cavity. Thebutt 42 ofnose needle 41 and the butt 52 ofpump needle 51 are each rigidly attached within these respective central needle recesses so that therespective needle points 43, 53 are coaxially aligned, centrally disposed within thecentral holes 22, 32, and in puncturing relationship to the ends of thecapsule 15 within the range of compressibility of thesprings 25, 35.
Additionally, theholders 40, 50 respectively comprisecircumannular shoulders 45, 55 which extend outwardly exactly as far as thewalls 23, 33 of the sleeve recesses of eachcompartment 20, 30. Thecircular sides 48, 58 of theshoulders 45, 55, opposite to the cavity for thecapsule 15, function as a stop means in cooperation with thenose sleeve 60 and thepump sleeve 70, respectively, and the outer cylindrical surfaces of theshoulders 45, 55 are in sliding contact with the innercylindrical surfaces 61, 71 of thesleeves 60, 70, thus functioning cooperatively therewith as an alignment means.
The nose andpump sleeve 60, respectively comprise elongated cylindrical portions, havingouter sides 62, 72 andinner sides 61, 71, and inwardly extendinginterior shoulders 65, 75, having respective cavityfacingcircular surfaces 66, 76, innercylindrical surfaces 68, 78, and endward-facingcircular surfaces 67, 77. Thesurfaces 68, 78 function as a sliding alignment means in cooperation with thecylindrical surfaces 46a, 56a of thefixed ends 46, 56 of theneedle holders 40, 50. Theinner side 61, 71 are non-slidably attached to the recessedouter surfaces 23, 33 and function cooperatively with the cylindrical outer surfaces of theshoulders 45, 55 as another sliding alignment means. Nonslidable attachment may be attained by means of suitable adhesive or by circumferential knurlings of the facing surfaces such as theknurlings 26 which are indicated in FIG. 6.
Thenose piece 80 comprises a taperedpenetration portion 82 through which passes thecentral discharge hole 81 therein. askirt portion 84 which extends toward thecavity 15, and a steppedportion 85 therebetween. An annular recess coincides with the inner edge of thestep portion 85 and penetrates longitudinally into thepenetration portion 82. Into this annular recess, thefixed end 46 of thenose needle holder 40 is rigidly attached. as with an adhesive. Theouter surface 62 of thenose sleeve 60 is in sliding engagement with the inner surface of theskirt 84 and functions cooperatively therewith as an alignment means.
The pump piece comprises anouter rim 91, abase 92 having an inwardly projecting circular lip to define thebase opening 98, acircular lug 94 spaced pumpward from the edge of therim 91, andcircumferential serrations 97 along the inner surface of thebase 92 and noseward of its circular lip. Thelug 94 has a circular and arcuately recedingsurface 95, which acts as a storage stop means when the inhaler is in its inverted storage position shown in FIG. 2, and a circular and radially extendingsurface 96 which acts as an operational stop means when the inhaler is inserted into aconventional pump 100, as shown in FIGS. 1, 3, and 4. Theserrations 97, which may be considered as ribbings, corrugations, or knurlings, are matched and engaged by similar serrations in thesurfaces 56a.
Thepump 100 typically has side walls 101, a circulartop edge 102 which engages thesurface 96 when theinhaler 8 is in operative position, and an air-containing interior 104 which should have sufficient depth to accommodate theinhaler 8 from the surface to the tip of thepenetration portion 82 when theinhaler 8 is in stored position partially within thepump 100.
In summary, theinhaler 8 comprises three pairs of slidable alignment means:
I. inner cylindrical surfaces ofskirt 84 and rim 91 in sliding contact with outercylindrical surfaces 62, 72; 2. innercylindrical surfaces 61, 71 in sliding contact with outer cylindrical surfaces of theshoulders 45, 55; and 3. innercylindrical surfaces 68, 78 in sliding contact with outer cylindrical surfaces 46:1, 560. Because of these three pairs of slidable alignment means, theinhaler 8 possesses a high degree of trueness so that binding and wear are minimized.
In FIGS. 1-4, the profile of the cylindrical surface of the lower body portion of theinhaler 8, which is connected by friction with a pump of suitable dimensions and configuration, is polished and uniform and interrupted by thelug 94 where circular lines ofcontact 95 and 96 with the cylindrical surface represent the stop points in locking engagement with thepump 100 when theinhaler 8 is ready to use and when it is in storage position, respectively.
The inhaling device operates as follows:
Initially, theinhaler 8, inverted in the pump 100 (as shown in FIG. 2 is extracted therefrom and connected by friction locking in its upright position to thepump 100.Compartment 20 is then screwed off fromcompartment 30 and thecapsule 15 of powder is inserted therein, after which nosepiece 80 andpumppiece 90 are moved towards one another, i.e., a contraction of the inhaler is caused along arrows AB, which creates two diametrally opposed perforations incapsule 15. Compare FIG. 1 with FIG. 4. Thereafter, it is possible to press thepump 100 to provoke the passage of the powder content of the capsule into a human cavity, such as nasal cavity or other cavities of the human body.
The present invention is not to be limited to the specific embodiment having the scope and advantages described hereinbefore, for various modifications can be made without departing from the spirit of the invention which should he understood asbeihglimited onlyiby the scope of the accompanying"claimst a 1. An inhalingdeyice, for-delivering powderedsubstances in aerated form from a pierced capsule, comprisinga pumpand. an inhaler, said inhalercomprising:
A. a, relatively fixed central element formed by two connectahle components and def ini ng a cavity. for reception of said capsule, and
B. a pair of relatively movcable ncc dleiholde'r ielm ments including piercing means mounted therein, which are: i IN 4 i r H l. telescopically slidable within said'corinectable components against the action of a pair of return springs and in the path of movement of air through said inhaler,
2. disposed in mutually opposed relationship and in straddling relationship to said capsule, and
3. constituting a means for piercing said capsule when said springs are compressed by slidably moving said needle holder elements toward each other.
2. The inhaling device of claim 1 whereinsaid components are connected by screw means.
3. The inhaling device of claim 1 wherein each of said pair of needle holer elements comprises a capsulepiercing needle.
4. The inhaling device of claim 1 wherein each of said components is attached to a sleeve having an interior shoulder and each of said pair of needle holder elements has an outwardly disposed shoulder which is capable of reciprocating between a rest position against one of said interior shoulders and a needle-piercing position against one of said conncctable components.
5. The inhaling device of claim 4 wherein said inhaler comprises a nose piece and a pump piece and one of said pair of said needle holder elements is locked by friction to said nose piece and the other of said pair of needle holder elements is locked against said pump piece by micro-ribs having saw teeth.
6. An inhaler for storing, entraining, and delivering powders in aerated condition, comprising;
A. a central storage unit for said powders,
B. a pair of needle holders including piercing means mounted therein which straddle said unit and are slidably connected thereto,
C. a nose piece which is non-slidably attached to one of said pair of needle holders,
D. a pump piece which is non-slidably attached to the other of said pair of needle holders, and
E. a longitudinally disposed air passage means extending from end to end of said inhaler, through said pump piece, said pair of needle holders, said central storage unit, and said nose piece, said nose piece and said pump piece ecah being longitudinally slidable toward said central storage unit to provide opposed piercing means for the central storage unit, whereby said powders are released.
7. The inhaler of claim 6 wherein said central storage unit comprises a pair of connectable compartments which define and contain. in combination, a cavity thcrewithin for storage of a capsule containing said powder.
8. The inhaler of claim 7 wherein each of said pair of conncctable compartments comprises an annular spring well within which a compression spring is seated.
'9. T he inhaler of claim.8 wherein each of said pair of needle holderscomprises a annular sliding end which is;slidably mounted within one of said annular spring wells andinengagement-with one .Of said springs.
10. The inhaler of claim 9.which further comprises a pair of stop:slceves which straddle said. unit and are non-slidably attached thereto.
11:. The inhaler ofclaim 10 wherein said pair of stop sleeves is in slidably circumferential and alignmentma'intaining relation to said pair of needle holder element's. 1 I
"12.The inhaler of claim 11- wherein each of said pair of stop sleeves has a cylindrical inner wall and said needle holders comprise circumanntilar shoulders which extend outwardly into slidable and alignmentmaintaining relation with said cylindrical inner walls of said stop sleeves.
13. The inhaler of claim 12 wherein each of said pair of needle holders additionally comprises an annular fixed end, one of said fixed ends being non-slidably attached to said nose piece and the other being nonslidably attached to said pump piece.
14. The inhaler ofclaim 13 wherein each of said pair of needle holders comprises a capsule-piercing needle, said needles being coaxially disposed in mutually opposed relationship and in straddling relationship to said capsule and being adapted to pierce said capsule when said springs are compressed by slidably moving said nose piece and said pump piece toward each other.
15. The inhaler of claim 14 wherein each of said stop sleeves additionally comprises an inwardly extending interior shoulder which extends into sliding engagement with exterior cylindrical surfaces of said fixed ends, as a sliding alignment means.
16. The inhaler ofclaim 15 wherein:
A. said nosepiece, said stop sleeves, and said central storage unit have a smaller exterior diameter than the exterior diameter of said pump piece, and
B. said pump piece comprises a circumferential and outwardly extending lug having an arcuately recedingsurface and a radially receding surface,
whereby said arcuately receding surface functions as a storage stop means, when said inhaler is inverted into a pump for storage by inserting said nose piece thereinto, and said radially receding surface functions as an operational stop means, when said inhaler is inserted into said pump by engaging said pump piece therewith.
17. The inhaler of claim 16 wherein said pump piece further has an exterior cylindrical surface which is polished and uniformly interrupted by a friction locking means for the mouthpiece of said pump.
18. The inhaling device of claim 17 wherein the points of contact between the cylindrical surface of the lower body portion and the surface normal to said means are friction locking points between said inhaler and said pump.
19. The inhaling device of claim 17 wherein the points of contact between the cylindrical surface of the lower body portion and the portions of said means have curved surfaces which are stop points for friction locking between said inhaler and said pump when said inhaling device is not in use.
20. The inhaling device ofclaim 5 wherein:
A. said nose piece and said. pump piece each comprises a skirt portion extending toward said cavity and having an inner cylindrical surface adapted for sliding contact; and
B. each said sleeve comprises an outer cylindrical surface adapted for said sliding contact with one of said inner cylindrical surfaces of said skirt portions of said nose piece and said pump piece to form a first pair of slidable alignment means.
21. The inhaling device of claim wherein:
Apeach said sleeve, attached to one of said two conncctahle components. comprises an inner cylindrical surface adapted for sliding contact; and
B. each said outwardly disposed shoulder of said pair of needle holder elements comprises an outer cylindrical surface adapted for said sliding contact with one of said sleeves to form a second pair of slidable alignment means.
22. The inhaling device of claim 21 wherein:
A. each said interior shoulder of said sleeves attached to said two components comprises an inner cylindrical surface adapted for sliding contact: and
Bi each said needle holder element comprises an outer cylindrical surface adapted for said sliding contact with one of said inner cylindrical surfaces of said interior shoulders to form a third slidable alignment means. said first, second. and third pairs of slidable alignment means imparting a high degree of trueness to said inhaler so that binding and wear are minimized.

Claims (24)

1. An inhaling device, for delivering powdered substances in aerated form from a pierced capsule, comprising a pump and an inhaler, said inhaler comprising: A. a relatively fixed central element formed by two connectable components and defining a cavity for reception of said capsule, and B. a pair of relatively moveable needle holder elements including piercing means mounted therein, which are: 1. telescopically slidable within said connectable components against the action of a pair of return springs and in the path of movement of air through said inhaler, 2. disposed in mutually opposed relationship and in straddling relationship to said capsule, and 3. constituting a means for piercing said capsule when said springs are compressed by slidably moving said needle holder elements toward each other.
6. An inhaler for storing, entraining, and delivering powders in aerated condition, comprising; A. a central storage unit for said powders, B. a apir of needle holders including piercing means mounted therein which straddle said unit and are slidably connected thereto, C. a nose piece which is non-slidably attached to one of said pair of needle holders, D. a pump piece which is non-slidably attached to the other of said pair of needle holders, and E. a longitudinally disposed air passage means extending from end to end of said inhaler, through said pump piece, said pair of needle holders, said central storage unit, and said nose piece, said nose piece and said pump piece ecah being longitudinally slidable toward said central storage unit to provide opposed piercing means for the central storage unit, whereby said powders are released.
US457270A1973-04-041974-04-02Inhaling device for powdered medicamentsExpired - LifetimeUS3906950A (en)

Applications Claiming Priority (2)

Application NumberPriority DateFiling DateTitle
IT2257673AIT986056B (en)1973-04-041973-04-04 INSUFFLATOR FOR POWDER-SHAPED MEDICATIONS
IT2569873AIT1045851B (en)1973-06-221973-06-22Inhaler for administering powdered medicaments - offers long term trouble free efficiency from particularly simple, inexpensive construction

Publications (1)

Publication NumberPublication Date
US3906950Atrue US3906950A (en)1975-09-23

Family

ID=26328226

Family Applications (1)

Application NumberTitlePriority DateFiling Date
US457270AExpired - LifetimeUS3906950A (en)1973-04-041974-04-02Inhaling device for powdered medicaments

Country Status (7)

CountryLink
US (1)US3906950A (en)
JP (1)JPS5048782A (en)
BE (1)BE813143A (en)
CH (1)CH569486A5 (en)
DE (2)DE2415961A1 (en)
FR (1)FR2224175B1 (en)
GB (1)GB1436813A (en)

Cited By (211)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4013075A (en)*1974-07-151977-03-22I.S.F. S.P.A.Inhalers and insufflators having a cutting means
US4069819A (en)*1973-04-131978-01-24Societa Farmaceutici S.P.A.Inhalation device
US4095596A (en)*1976-11-261978-06-20Smithkline CorporationNasal inhaler
US4105027A (en)*1975-06-131978-08-08Syntex Puerto Rico, Inc.Inhalation device
US4116195A (en)*1976-02-101978-09-26Allen & Hanburys LimitedDevice for dispensing medicaments
US4240418A (en)*1974-08-221980-12-23Schering AktiengesellschaftApparatus for the inhalation of medicinal agents
US4338931A (en)*1979-04-271982-07-13Claudio CavazzaDevice for the quick inhalation of drugs in powder form by humans suffering from asthma
US4446862A (en)*1979-10-301984-05-08Baum Eric ABreath actuated devices for administering powdered medicaments
US4620847A (en)*1984-06-011986-11-04Vsesojuzny Nauchno-Issledovatelsky Institut Meditsinskikh PolimerovDevice for administering powdered substances
US4645487A (en)*1984-06-051987-02-24Vsesojuzny Nauchno-Issledovatelsky Institut Meditsinskikh PolimerovDevice for administering powdered substances
US4884565A (en)*1987-08-171989-12-05Miat S.P.A.Insufflator for the administration of drugs in the form of a powder pre-dosed into opercola
US4889114A (en)*1983-12-171989-12-26Boehringer Ingelheim KgPowdered pharmaceutical inhaler
US5033463A (en)*1989-10-271991-07-23Miat S.P.A.Multi-dose inhaler for medicaments in powder form
US5152284A (en)*1989-02-231992-10-06Phidea S.P.A.Disposable inhaler with pre-pierced capsule
US5161524A (en)*1991-08-021992-11-10Glaxo Inc.Dosage inhalator with air flow velocity regulating means
US5366122A (en)*1991-08-271994-11-22Ing. Erich Pfeiffer Gmbh & Co. KgDispenser for flowable media
US5388572A (en)*1993-10-261995-02-14Tenax Corporation (A Connecticut Corp.)Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
US5388573A (en)*1993-12-021995-02-14Tenax CorporationDry powder inhalator medicament carrier
US5460173A (en)*1993-03-031995-10-24Tenax CorporationDry powder inhaler medicament carrier
US5488946A (en)*1994-03-011996-02-06Calhoun; Clifford A.Emergency breathing device for opening cartridges
WO1996012513A1 (en)*1994-10-241996-05-02Oxford Biosciences LimitedParticle delivery
US5617845A (en)*1990-08-301997-04-08Boehringer Ingelheim KgInhalation device free from propellent gas
US5692496A (en)*1995-08-021997-12-02Innovative Devices, LlcDry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
US5715811A (en)*1994-05-261998-02-10Unisia Jecs CorporationInhaling type medicine administering device and using method therefor
US5752505A (en)*1996-03-211998-05-19Unisia Jecs CorporationInhalation-type medicine delivery device
US5810004A (en)*1995-10-091998-09-22Unisia Jecs CorporationMedicator for a capsule filled with a powdered drug
US5823183A (en)*1995-08-021998-10-20Innovative DevicesDry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
EP0761248A4 (en)*1995-03-101998-12-23Unisia Jecs Corp DISTRIBUTOR FOR INTRANASANAL DRUGS
WO1998058695A1 (en)*1997-06-231998-12-30Marco CecchiniInhaling device
US5901703A (en)*1995-02-061999-05-11Unisia Jecs CorporationMedicine administering device for nasal cavities
US5988163A (en)*1995-08-021999-11-23Innovative DevicesDry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of delivery of medicament
US6013050A (en)*1995-10-202000-01-11Powderject Research LimitedParticle delivery
US6048857A (en)*1989-10-172000-04-11Ellinwood, Jr.; Everett H.Dosing method of administering medicaments via inhalation administration
US6186141B1 (en)*1996-05-102001-02-13Glaxo Wellcome Inc.Unit dose dispensing device
US6209538B1 (en)*1995-08-022001-04-03Robert A. CasperDry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
US6273086B1 (en)*1998-02-062001-08-14Unisia Jecs CorporationInhalant medicator
US20010029947A1 (en)*1999-12-172001-10-18Steve PaboojianReceptacles to facilitate the extraction of powders
US6341605B1 (en)*1998-02-052002-01-29Unisia Jecs CorporationInhalant medicator
US20020134382A1 (en)*2000-05-102002-09-26Snow John M.Medicament container with same side airflow inlet and outlet and method of use
US6546929B2 (en)1998-06-042003-04-15Inhale Therapeutic Systems, Inc.Dry powder dispersing apparatus and methods for their use
US20030131847A1 (en)*2002-01-162003-07-17Fabrizio NiccolaiDevice usable in the treatment of affections of the airways
US20030150454A1 (en)*2001-11-142003-08-14Inhale Therapeutic Systems, Inc.Aerosolization apparatus with removable mouthpiece
EP1108439A3 (en)*1999-12-152003-09-10Ing. Erich Pfeiffer GmbHProduct dispenser
US6681768B2 (en)2001-06-222004-01-27Sofotec Gmbh & Co. KgPowder formulation disintegrating system and method for dry powder inhalers
US20040077528A1 (en)*1999-06-292004-04-22Mannkind CorporationPurification and stabilization of peptide and protein pharmaceutical agents
US6732732B2 (en)2001-04-162004-05-11Advanced Inhalation Research, Inc.Inhalation device and method
US20040096403A1 (en)*1995-05-152004-05-20Mannkind CorporationMethod for drug delivery to the pulmonary system
US20040182387A1 (en)*1999-07-232004-09-23Mannkind CorporationUnit dose cartridge and dry powder inhaler
US20040206350A1 (en)*2002-12-192004-10-21Nektar TherapeuticsAerosolization apparatus with non-circular aerosolization chamber
US20050028813A1 (en)*2001-10-052005-02-10Ian HarrisonApparatus for the nasal or oral delivery of a medicament
US20050088617A1 (en)*2003-10-272005-04-28Jen-Chuen HsiehMethod and apparatus for visual drive control
US20050150492A1 (en)*2003-04-092005-07-14Nektar TherapeuticsAerosolization apparatus with air inlet shield
US20050153874A1 (en)*2004-01-122005-07-14Mannkind CorporationMethod of reducing serum proinsulin levels in type 2 diabetics
US20050177095A1 (en)*2002-05-142005-08-11Tatsuo TsutsuiPowder chemical feeding device for nasal cavity
US20050186146A1 (en)*2004-02-122005-08-25Nektar TherapeuticsInterleukin-13 antagonist powders, spray-dried particles, and methods
US20050250705A1 (en)*2004-05-102005-11-10Boehringer Ingelheim Pharma Gmbh Co. KgSpray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation
US20050250704A1 (en)*2004-05-102005-11-10Boehringer Ingelheim Pharma Gmbh & Co. KgPowder comprising new compositions of oligosaccharides and methods for their preparation
US20050255119A1 (en)*2004-05-102005-11-17Boehringer Ingelheim Pharma Gmbh & Co. Kg1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
US6978941B2 (en)2001-05-022005-12-27Aerogen, Inc.Base isolated nebulizing device and methods
US7032593B2 (en)2000-08-142006-04-25Advanced Inhalation Research, Inc.Inhalation device and method
US7032590B2 (en)2001-03-202006-04-25Aerogen, Inc.Fluid filled ampoules and methods for their use in aerosolizers
US7040549B2 (en)1991-04-242006-05-09Aerogen, Inc.Systems and methods for controlling fluid feed to an aerosol generator
WO2006051300A1 (en)2004-11-102006-05-18Cipla LimitedInhaler
US7066398B2 (en)1999-09-092006-06-27Aerogen, Inc.Aperture plate and methods for its construction and use
US7112341B1 (en)1999-04-132006-09-26Nektar TherapeuticsPulmonary administration of dry powder formulations for treating infertility
US20070020191A1 (en)*1999-06-292007-01-25Mannkind CorporationPotentiation of glucose elimination
US7174888B2 (en)1995-04-052007-02-13Aerogen, Inc.Liquid dispensing apparatus and methods
US20070051362A1 (en)*2004-04-232007-03-08Sullivan Timothy RMultiple unit dose drug delivery system
US7195011B2 (en)2001-03-202007-03-27Aerogen, Inc.Convertible fluid feed system with comformable reservoir and methods
US7201167B2 (en)2004-04-202007-04-10Aerogen, Inc.Method and composition for the treatment of lung surfactant deficiency or dysfunction
US20070086952A1 (en)*2005-09-292007-04-19Biodel, Inc.Rapid Acting and Prolonged Acting Inhalable Insulin Preparations
WO2007098870A1 (en)*2006-02-242007-09-07Aha Kunststofftechnik GmbhDry powder inhaler
US20070209659A1 (en)*1995-04-052007-09-13Aerogen, Inc.Liquid dispensing apparatus and methods
US7290541B2 (en)2004-04-202007-11-06Aerogen, Inc.Aerosol delivery apparatus and method for pressure-assisted breathing systems
US20070283955A1 (en)*2006-06-072007-12-13Bioactis LimitesPeroral powder delivery device
US7322349B2 (en)2000-05-052008-01-29Aerogen, Inc.Apparatus and methods for the delivery of medicaments to the respiratory system
US20080039368A1 (en)*2006-04-122008-02-14Biodel Inc.Rapid acting and long acting insulin combination formulations
US7331339B2 (en)2000-05-052008-02-19Aerogen, Inc.Methods and systems for operating an aerosol generator
US20080053437A1 (en)*1999-07-232008-03-06Mannkind CorporationUnit dose capsules and dry powder inhaler
US20080063606A1 (en)*2001-12-192008-03-13Tarara Thomas EPulmonary delivery of aminoglycoside
US20080090753A1 (en)*2004-03-122008-04-17Biodel, Inc.Rapid Acting Injectable Insulin Compositions
US7360536B2 (en)2002-01-072008-04-22Aerogen, Inc.Devices and methods for nebulizing fluids for inhalation
US20080177246A1 (en)*2007-01-092008-07-24First City TowerIntranasal Cartridge Devices
US20080248999A1 (en)*2007-04-042008-10-09Biodel Inc.Amylin formulations
US20090025721A1 (en)*2007-06-122009-01-29Alkermes, Inc.Powder inhaler devices
US20090071108A1 (en)*2007-09-142009-03-19Mystic Pharmaceuticals, Inc.Deep draw container forming method
US20090090433A1 (en)*2005-05-182009-04-09Symyx Technologies Europe SaApparatus And Method For Storing And Dispensing Material, Especially In Micro Quantities And In Combination With Limited Starting Amounts
US20090117193A1 (en)*1999-10-292009-05-07Nektar TherapeuticsCompositions Comprising an Active Agent
US20090137455A1 (en)*2005-09-292009-05-28Biodel Inc.Rapid acting and long acting insulin combination formulations
US20090175840A1 (en)*2008-01-042009-07-09Biodel, Inc.Insulin formulations for insulin release as a function of tissue glucose levels
US20090194105A1 (en)*2006-04-132009-08-06Jens BesselerInhaler
US20090241949A1 (en)*2008-03-272009-10-01Smutney Chad CDry powder inhalation system
US7600511B2 (en)2001-11-012009-10-13Novartis Pharma AgApparatus and methods for delivery of medicament to a respiratory system
US7628339B2 (en)1991-04-242009-12-08Novartis Pharma AgSystems and methods for controlling fluid feed to an aerosol generator
US20090320838A1 (en)*2006-06-162009-12-31Cipla LimitedDry powder inhaler
US7669597B2 (en)2007-05-162010-03-02Mystic Pharmaceuticals, Inc.Combination unit dose dispensing containers
US7677467B2 (en)2002-01-072010-03-16Novartis Pharma AgMethods and devices for aerosolizing medicament
US7713929B2 (en)2006-04-122010-05-11Biodel Inc.Rapid acting and long acting insulin combination formulations
US7771642B2 (en)2002-05-202010-08-10Novartis AgMethods of making an apparatus for providing aerosol for medical treatment
US20100288275A1 (en)*2007-04-052010-11-18Optinose AsNasal administration
US20100287884A1 (en)*2007-10-252010-11-18Sangita SeshadriPowder conditioning of unit dose drug packages
US20100313886A1 (en)*2007-08-012010-12-16Herbert WachtelInhaler
US20110033544A1 (en)*2009-05-152011-02-10Shin Nippon Biomedical Laboratories, Ltd.Intranasal pharmaceutical compositions with improved pharmacokinetcs
US20110045088A1 (en)*2009-07-312011-02-24Shin Nippon Biomedical Laboratories, Ltd.Intranasal granisetron and nasal applicator
US20110056488A1 (en)*2008-01-242011-03-10Vectura Delivery Devices LimitedInhaler
US7946291B2 (en)2004-04-202011-05-24Novartis AgVentilation systems and methods employing aerosol generators
US7971588B2 (en)2000-05-052011-07-05Novartis AgMethods and systems for operating an aerosol generator
US20110171312A1 (en)*2008-09-192011-07-14Nektar TherapeuticsModified therapeutic peptides, methods of their preparation and use
WO2011163518A1 (en)2010-06-242011-12-29Gilead Sciences, Inc.Pyrazolo [1, 5 -a] pyrimidines as antiviral agents
WO2012012776A1 (en)2010-07-222012-01-26Gilead Sciences, Inc.Methods and compounds for treating paramyxoviridae virus infections
WO2012037038A1 (en)2010-09-132012-03-22Gilead Sciences, Inc.2' -fluoro substituted carba-nucleoside analogs for antiviral treatment
WO2012106382A1 (en)2011-01-312012-08-09Genoa Pharmaceuticals, Inc.Aerosol pirfenidone and pyridone analog compounds and uses thereof
US8336545B2 (en)2000-05-052012-12-25Novartis Pharma AgMethods and systems for operating an aerosol generator
US8357696B2 (en)2005-05-182013-01-22Mpex Pharmaceuticals, Inc.Aerosolized fluoroquinolones and uses thereof
WO2013016787A1 (en)2011-08-042013-02-07Victor EstevePowder inhaler
EP2594272A2 (en)2005-05-182013-05-22Mpex Pharmaceuticals, Inc.Aerosolized fluoroquinolones and uses thereof
US8561609B2 (en)2010-12-072013-10-22Respira Therapeutics, Inc.Dry powder inhaler
WO2013158776A1 (en)2012-04-172013-10-24Gilead Sciences, Inc.Compounds and methods for antiviral treatment
US20130327327A1 (en)*2012-06-062013-12-12Aerodesigns, Inc.Aerosol dispenser with replaceable cartridge
US8616195B2 (en)2003-07-182013-12-31Novartis AgNebuliser for the production of aerosolized medication
US8623817B2 (en)2008-08-112014-01-07Mannkind CorporationMethod of treating diabetes type 2 by administering ultrarapid acting insulin
US8629139B2 (en)2008-10-072014-01-14Mpex Pharmaceuticals, Inc.Topical use of Levofloxacin for reducing lung inflammation
US8664187B2 (en)2004-06-182014-03-04Novartis AgMethods of treatment of endobronchial infections
US8673360B2 (en)2004-08-102014-03-18Shin Nippon Biomedical Laboratories, Ltd.Compositions that enable rapid-acting and highly absorptive intranasal administration
US8683995B2 (en)2007-05-162014-04-01Mystic Pharmaceuticals, Inc.Dose dispensing containers
US8785396B2 (en)2007-10-242014-07-22Mannkind CorporationMethod and composition for treating migraines
US8815838B2 (en)2008-10-072014-08-26David C. GriffithAerosol fluoroquinolone formulations for improved pharmacokinetics
US8869794B1 (en)*2003-04-092014-10-28Novartis Pharma AgAerosolization apparatus with capsule puncturing member
WO2015006838A1 (en)2013-07-162015-01-22Victor EstevePowder inhaler
USRE45404E1 (en)2003-03-272015-03-03Shin Nippon Biomedical Laboratories, Ltd.Powder medicine applicator for nasal cavity
US9060927B2 (en)2009-03-032015-06-23Biodel Inc.Insulin formulations for rapid uptake
US9108211B2 (en)2005-05-252015-08-18Nektar TherapeuticsVibration systems and methods
US9138410B2 (en)2003-02-212015-09-22Shin Nippon Biomedical Laboratories, Ltd.Compositions for nasal administration of pharmaceuticals
US9192675B2 (en)2008-06-132015-11-24Mankind CorporationDry powder inhaler and system for drug delivery
US9220687B2 (en)2008-12-292015-12-29Mannkind CorporationSubstituted diketopiperazine analogs for use as drug delivery agents
US9233159B2 (en)2011-10-242016-01-12Mannkind CorporationMethods and compositions for treating pain
USD748242S1 (en)2014-07-112016-01-26H. Stuart CampbellInhaler mouthpiece
US9241903B2 (en)2006-02-222016-01-26Mannkind CorporationMethod for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US9248076B2 (en)2007-05-162016-02-02Mystic Pharmaceuticals, Inc.Dose dispensing containers
WO2016018697A1 (en)2014-07-282016-02-04Gilead Sciences, Inc.Thieno [3,2-d] pyrimidine, furo [3,2,d] pyrimidine, and pyrrolo [3,2-d] pyrimidines useful for treating respiratory syncitial virus infections
US9283193B2 (en)2005-09-142016-03-15Mannkind CorporationMethod of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
USD752204S1 (en)2014-03-102016-03-22Civitas Therapeutics, Inc.Indicator for an inhaler
USD752734S1 (en)2014-03-102016-03-29Civitas Therapeutics, Inc.Inhaler grip
US20160095989A1 (en)*2004-09-152016-04-07Optinose AsNasal delivery devices
USD755367S1 (en)2014-03-102016-05-03Civitas Therapeutics, Inc.Indicator for an inhaler
US9346766B2 (en)2004-08-202016-05-24Mannkind CorporationCatalysis of diketopiperazine synthesis
US9364619B2 (en)2008-06-202016-06-14Mannkind CorporationInteractive apparatus and method for real-time profiling of inhalation efforts
US9364436B2 (en)2011-06-172016-06-14Mannkind CorporationHigh capacity diketopiperazine microparticles and methods
US9492625B2 (en)2009-11-122016-11-15Stc.UnmDry powder inhaler with flutter dispersion member
US20170006917A1 (en)*2015-07-072017-01-12Altria Client Services Inc.E-vapor device including capsule containing pre-vapor formulation
US9550036B2 (en)2011-03-032017-01-24Impel Neuropharma Inc.Nasal drug delivery device
US9630930B2 (en)2009-06-122017-04-25Mannkind CorporationDiketopiperazine microparticles with defined specific surface areas
US9662461B2 (en)2008-06-132017-05-30Mannkind CorporationDry powder drug delivery system and methods
WO2017094027A1 (en)*2015-12-012017-06-08Cipla LimitedNasal spray assembly
US9675674B2 (en)2004-08-232017-06-13Mannkind CorporationDiketopiperazine salts for drug delivery and related methods
US9682153B2 (en)2008-09-192017-06-20Nektar TherapeuticsPolymer conjugates of therapeutic peptides
US9700690B2 (en)2002-03-202017-07-11Mannkind CorporationInhalation apparatus
US9700564B2 (en)2009-09-042017-07-11Horizon Orphan LlcUse of aerosolized levofloxacin for treating cystic fibrosis
US9706944B2 (en)2009-11-032017-07-18Mannkind CorporationApparatus and method for simulating inhalation efforts
EP3210993A1 (en)2012-03-132017-08-30Gilead Sciences, Inc.2'- substituted carba-nucleoside analogs for antiviral treatment
US9757529B2 (en)2012-12-202017-09-12Otitopic Inc.Dry powder inhaler and methods of use
US9757395B2 (en)2012-12-202017-09-12Otitopic Inc.Dry powder inhaler and methods of use
US9802012B2 (en)2012-07-122017-10-31Mannkind CorporationDry powder drug delivery system and methods
US9919117B2 (en)2011-05-092018-03-20Impel Neuropharma Inc.Nozzles for nasal drug delivery
US9925144B2 (en)2013-07-182018-03-27Mannkind CorporationHeat-stable dry powder pharmaceutical compositions and methods
US9983108B2 (en)2009-03-112018-05-29Mannkind CorporationApparatus, system and method for measuring resistance of an inhaler
US9993488B2 (en)2014-02-202018-06-12Otitopic Inc.Dry powder formulations for inhalation
US10016582B2 (en)2008-02-072018-07-10University Of Washington Through Its Center For CommercializationCircumferential aerosol device
US10028966B2 (en)2014-01-102018-07-24Avalyn Pharma Inc.Aerosol pirfenidone and pyridone analog compounds and uses thereof
US10149823B2 (en)2013-04-302018-12-11Otitopic Inc.Dry powder formulations and methods of use
US10159644B2 (en)2012-10-262018-12-25Mannkind CorporationInhalable vaccine compositions and methods
CN109078245A (en)*2018-10-112018-12-25上海博极给药医药科技有限公司A kind of double-capsule type powder inhaler
US10195139B2 (en)2006-12-262019-02-05Shin Nippon Biomedical Laboratories, Ltd.Preparation for transnasal application
US10207065B2 (en)2013-07-122019-02-19John H. SilvaMouthpiece for inhalers
US10307464B2 (en)2014-03-282019-06-04Mannkind CorporationUse of ultrarapid acting insulin
EP3505173A1 (en)2013-11-112019-07-03Gilead Sciences, Inc.Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections
US10342938B2 (en)2008-06-132019-07-09Mannkind CorporationDry powder drug delivery system
US10421729B2 (en)2013-03-152019-09-24Mannkind CorporationMicrocrystalline diketopiperazine compositions and methods
US10441733B2 (en)2012-06-252019-10-15Respira Therapeutics, Inc.Powder dispersion devices and methods
US10537692B2 (en)2013-04-282020-01-21Impel Neuropharma, Inc.Medical unit dose container
US10561806B2 (en)2014-10-022020-02-18Mannkind CorporationMouthpiece cover for an inhaler
US10625034B2 (en)2011-04-012020-04-21Mannkind CorporationBlister package for pharmaceutical cartridges
CN111372635A (en)*2017-11-212020-07-03英倍尔药业股份有限公司Intranasal device with access port
US20200289769A1 (en)*2017-10-122020-09-17Aptar France SasDevice for dispensing a fluid product
EP3738969A1 (en)2014-08-212020-11-18Gilead Sciences, Inc.2'-chloro aminopyrimidinone and pyrimidine dione nucleosides for use in treating pneumovirinae virus infections
EP3782604A1 (en)2013-07-312021-02-24Windward Pharma, Inc.Aerosol tyrosine kinase inhibitor compounds and uses thereof
WO2021130638A1 (en)2019-12-242021-07-01Carna Biosciences, Inc.Diacylglycerol kinase modulating compounds
WO2021168038A1 (en)2020-02-182021-08-26Gilead Sciences, Inc.Antiviral compounds
WO2021167882A1 (en)2020-02-182021-08-26Gilead Sciences, Inc.Antiviral compounds
WO2021168004A1 (en)2020-02-182021-08-26Gilead Sciences, Inc.Antiviral compounds
WO2021168008A1 (en)2020-02-182021-08-26Gilead Sciences, Inc.A 5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2-cyano-3,4-dihydroxytetrahydrofurane derivative as antiviral agent
WO2021222522A1 (en)2020-05-012021-11-04Gilead Sciences, Inc.Cd73 inhibiting 2,4-dioxopyrimidine compounds
US11185497B2 (en)2018-01-052021-11-30Impel Neuropharma, Inc.Intranasal delivery of dihydroergotamine by precision olfactory device
US11266799B2 (en)2015-09-102022-03-08Impel Neuropharma, Inc.In-line nasal delivery device
US11273268B2 (en)*2016-07-072022-03-15Philip Morris Products S.A.Nicotine inhaler system
US11278492B2 (en)2018-01-052022-03-22Impel Neuropharma, Inc.Intranasal delivery of olanzapine by precision olfactory device
US11446127B2 (en)2013-08-052022-09-20Mannkind CorporationInsufflation apparatus and methods
US11471623B2 (en)2012-02-212022-10-18Respira Therapeutics, Inc.Powder dispersion methods and devices
WO2022240897A1 (en)2021-05-102022-11-17Sepelo Therapeutics, LlcPharmaceutical composition comprising delafloxacin for administration into the lung
US11517548B2 (en)2018-07-192022-12-06Impel Pharmaceuticals Inc.Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's Disease
WO2022271650A1 (en)2021-06-232022-12-29Gilead Sciences, Inc.Diacylglyercol kinase modulating compounds
WO2022271684A1 (en)2021-06-232022-12-29Gilead Sciences, Inc.Diacylglyercol kinase modulating compounds
WO2022271659A1 (en)2021-06-232022-12-29Gilead Sciences, Inc.Diacylglyercol kinase modulating compounds
WO2022271677A1 (en)2021-06-232022-12-29Gilead Sciences, Inc.Diacylglyercol kinase modulating compounds
US11571532B2 (en)2017-11-212023-02-07Impel Pharmaceuticals Inc.Intranasal device with dip tube
WO2023028364A1 (en)2021-08-272023-03-02Sepelo Therapeutics, LlcTargeted compositions and uses therof
WO2023077030A1 (en)2021-10-292023-05-04Gilead Sciences, Inc.Cd73 compounds
US11744967B2 (en)2017-09-262023-09-05Shin Nippon Biomedical Laboratories, Ltd.Intranasal delivery devices
US11759585B2 (en)2019-01-032023-09-19Impel Pharmaceuticals Inc.Nasal drug delivery device with detachable nozzle
US11878109B2 (en)2019-05-172024-01-23Impel Pharmaceuticals Inc.Single-use nasal delivery device
WO2025120297A1 (en)*2023-12-062025-06-12Industrial Design Consultancy LtdPowder dispensers

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
DK198591D0 (en)*1991-12-101991-12-10Novo Nordisk As APPARATUS
DE19533979A1 (en)*1995-09-141997-03-20Alfred Von Schuckmann Device for the dosed, airborne delivery of substances

Citations (7)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US2307986A (en)*1940-02-151943-01-12BolteInsufflator
US2517482A (en)*1949-04-091950-08-01Sharp & Dohme IncInhaler
US2519555A (en)*1945-08-311950-08-22Abbott LabSterile medicament insufflator cartridge and insufflator
US2581182A (en)*1950-03-141952-01-01Abbott LabInhaler
US2946332A (en)*1957-12-231960-07-26Nysco Lab IncInsufflator
US3507277A (en)*1966-09-171970-04-21Fisons Pharmaceuticals LtdInhalation device
US3669113A (en)*1966-03-071972-06-13Fisons LtdInhalation device

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US2307986A (en)*1940-02-151943-01-12BolteInsufflator
US2519555A (en)*1945-08-311950-08-22Abbott LabSterile medicament insufflator cartridge and insufflator
US2517482A (en)*1949-04-091950-08-01Sharp & Dohme IncInhaler
US2581182A (en)*1950-03-141952-01-01Abbott LabInhaler
US2946332A (en)*1957-12-231960-07-26Nysco Lab IncInsufflator
US3669113A (en)*1966-03-071972-06-13Fisons LtdInhalation device
US3507277A (en)*1966-09-171970-04-21Fisons Pharmaceuticals LtdInhalation device

Cited By (359)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4069819A (en)*1973-04-131978-01-24Societa Farmaceutici S.P.A.Inhalation device
US4013075A (en)*1974-07-151977-03-22I.S.F. S.P.A.Inhalers and insufflators having a cutting means
US4240418A (en)*1974-08-221980-12-23Schering AktiengesellschaftApparatus for the inhalation of medicinal agents
US4105027A (en)*1975-06-131978-08-08Syntex Puerto Rico, Inc.Inhalation device
US4116195A (en)*1976-02-101978-09-26Allen & Hanburys LimitedDevice for dispensing medicaments
US4095596A (en)*1976-11-261978-06-20Smithkline CorporationNasal inhaler
US4338931A (en)*1979-04-271982-07-13Claudio CavazzaDevice for the quick inhalation of drugs in powder form by humans suffering from asthma
US4446862A (en)*1979-10-301984-05-08Baum Eric ABreath actuated devices for administering powdered medicaments
US4889114A (en)*1983-12-171989-12-26Boehringer Ingelheim KgPowdered pharmaceutical inhaler
US4620847A (en)*1984-06-011986-11-04Vsesojuzny Nauchno-Issledovatelsky Institut Meditsinskikh PolimerovDevice for administering powdered substances
US4645487A (en)*1984-06-051987-02-24Vsesojuzny Nauchno-Issledovatelsky Institut Meditsinskikh PolimerovDevice for administering powdered substances
US4884565A (en)*1987-08-171989-12-05Miat S.P.A.Insufflator for the administration of drugs in the form of a powder pre-dosed into opercola
AU602603B2 (en)*1987-08-171990-10-18Miat S.P.A.Insufflator for the administration of drugs in the form of a powder pre-dosed into opercola
US5152284A (en)*1989-02-231992-10-06Phidea S.P.A.Disposable inhaler with pre-pierced capsule
US6048857A (en)*1989-10-172000-04-11Ellinwood, Jr.; Everett H.Dosing method of administering medicaments via inhalation administration
US5033463A (en)*1989-10-271991-07-23Miat S.P.A.Multi-dose inhaler for medicaments in powder form
US5617845A (en)*1990-08-301997-04-08Boehringer Ingelheim KgInhalation device free from propellent gas
US7040549B2 (en)1991-04-242006-05-09Aerogen, Inc.Systems and methods for controlling fluid feed to an aerosol generator
US7628339B2 (en)1991-04-242009-12-08Novartis Pharma AgSystems and methods for controlling fluid feed to an aerosol generator
US5161524A (en)*1991-08-021992-11-10Glaxo Inc.Dosage inhalator with air flow velocity regulating means
US5366122A (en)*1991-08-271994-11-22Ing. Erich Pfeiffer Gmbh & Co. KgDispenser for flowable media
US5460173A (en)*1993-03-031995-10-24Tenax CorporationDry powder inhaler medicament carrier
US5388572A (en)*1993-10-261995-02-14Tenax Corporation (A Connecticut Corp.)Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
US5388573A (en)*1993-12-021995-02-14Tenax CorporationDry powder inhalator medicament carrier
US5488946A (en)*1994-03-011996-02-06Calhoun; Clifford A.Emergency breathing device for opening cartridges
US5653191A (en)*1994-03-011997-08-05Calhoun; Clifford A.Pressure indicator
US5715811A (en)*1994-05-261998-02-10Unisia Jecs CorporationInhaling type medicine administering device and using method therefor
WO1996012513A1 (en)*1994-10-241996-05-02Oxford Biosciences LimitedParticle delivery
US5901703A (en)*1995-02-061999-05-11Unisia Jecs CorporationMedicine administering device for nasal cavities
US5921236A (en)*1995-03-101999-07-13Unisia Jecs CorporationMedicine administering device for nasal cavities
EP0761248A4 (en)*1995-03-101998-12-23Unisia Jecs Corp DISTRIBUTOR FOR INTRANASANAL DRUGS
US8561604B2 (en)1995-04-052013-10-22Novartis AgLiquid dispensing apparatus and methods
US7174888B2 (en)1995-04-052007-02-13Aerogen, Inc.Liquid dispensing apparatus and methods
US20070209659A1 (en)*1995-04-052007-09-13Aerogen, Inc.Liquid dispensing apparatus and methods
US8394414B2 (en)1995-05-152013-03-12Mannkind CorporationMethod for drug delivery to the pulmonary system
US20040096403A1 (en)*1995-05-152004-05-20Mannkind CorporationMethod for drug delivery to the pulmonary system
US5988163A (en)*1995-08-021999-11-23Innovative DevicesDry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of delivery of medicament
US6209538B1 (en)*1995-08-022001-04-03Robert A. CasperDry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
US5692496A (en)*1995-08-021997-12-02Innovative Devices, LlcDry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
US6561186B2 (en)1995-08-022003-05-13Innovative DevicesDry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
US6550477B1 (en)1995-08-022003-04-22Innovative Devices, LlcDry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
US5823183A (en)*1995-08-021998-10-20Innovative DevicesDry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
US5810004A (en)*1995-10-091998-09-22Unisia Jecs CorporationMedicator for a capsule filled with a powdered drug
US6013050A (en)*1995-10-202000-01-11Powderject Research LimitedParticle delivery
US5752505A (en)*1996-03-211998-05-19Unisia Jecs CorporationInhalation-type medicine delivery device
US6186141B1 (en)*1996-05-102001-02-13Glaxo Wellcome Inc.Unit dose dispensing device
WO1998058695A1 (en)*1997-06-231998-12-30Marco CecchiniInhaling device
US6341605B1 (en)*1998-02-052002-01-29Unisia Jecs CorporationInhalant medicator
US6273086B1 (en)*1998-02-062001-08-14Unisia Jecs CorporationInhalant medicator
US20030209243A1 (en)*1998-06-042003-11-13Inhale Therapeutic SystemsDry powder dispersing apparatus and methods for their use
US6901929B2 (en)1998-06-042005-06-07Nektar TherapeuticsDry powder dispersing apparatus and methods for their use
US6546929B2 (en)1998-06-042003-04-15Inhale Therapeutic Systems, Inc.Dry powder dispersing apparatus and methods for their use
US8161969B2 (en)1998-06-042012-04-24Novartis AgDry powder dispersing apparatus and methods for their use
US7422013B2 (en)1998-06-042008-09-09Nektar TherapeuticsDry powder dispersing apparatus and methods for their use
US20080230058A1 (en)*1998-06-042008-09-25Nektar TherapeuticsDry powder dispersing apparatus and methods for their use
US7112341B1 (en)1999-04-132006-09-26Nektar TherapeuticsPulmonary administration of dry powder formulations for treating infertility
US7648960B2 (en)1999-06-292010-01-19Mannkind CorporationMethod for delivery of monomeric or dimeric insulin complexed to diketopiperazine microparticles
US20110105391A1 (en)*1999-06-292011-05-05Mannkind CorporationMethods and Compositions for Delivering Peptides
US20100086609A1 (en)*1999-06-292010-04-08Mannkind CorporationMethods and Compositions for Delivering Peptides
US8889099B2 (en)1999-06-292014-11-18Mannkind CorporationMethods and compositions for delivering peptides
US8389470B2 (en)1999-06-292013-03-05Mannkind CorporationMethods and compositions for delivering peptides
US20040077528A1 (en)*1999-06-292004-04-22Mannkind CorporationPurification and stabilization of peptide and protein pharmaceutical agents
US20070020191A1 (en)*1999-06-292007-01-25Mannkind CorporationPotentiation of glucose elimination
US9801925B2 (en)1999-06-292017-10-31Mannkind CorporationPotentiation of glucose elimination
US9006175B2 (en)1999-06-292015-04-14Mannkind CorporationPotentiation of glucose elimination
US7943178B2 (en)1999-06-292011-05-17Mannkind CorporationMethods and compositions for delivering peptides
US20080190425A1 (en)*1999-07-232008-08-14Steiner Solomon SUnit dose cartridge and dry powder inhaler
US20080053437A1 (en)*1999-07-232008-03-06Mannkind CorporationUnit dose capsules and dry powder inhaler
US8950397B2 (en)1999-07-232015-02-10Mannkind CorporationUnit dose cartridge and dry powder inhaler
US8671937B2 (en)1999-07-232014-03-18Mannkind CorporationUnit dose capsules and dry powder inhaler
US20040182387A1 (en)*1999-07-232004-09-23Mannkind CorporationUnit dose cartridge and dry powder inhaler
US9061111B2 (en)1999-07-232015-06-23Mannkind CorporationUnit dose capsules and dry powder inhaler
US8156936B2 (en)1999-07-232012-04-17Mannkind CorporationUnit dose capsules and dry powder inhaler
US8215300B2 (en)1999-07-232012-07-10Mannkind CorporationUnit dose cartridge and dry powder inhaler
US7464706B2 (en)1999-07-232008-12-16Mannkind CorporationUnit dose cartridge and dry powder inhaler
US8398001B2 (en)1999-09-092013-03-19Novartis AgAperture plate and methods for its construction and use
US7066398B2 (en)1999-09-092006-06-27Aerogen, Inc.Aperture plate and methods for its construction and use
US20070023547A1 (en)*1999-09-092007-02-01Aerogen, Inc.Aperture plate and methods for its construction and use
US20090117193A1 (en)*1999-10-292009-05-07Nektar TherapeuticsCompositions Comprising an Active Agent
US8501240B2 (en)1999-10-292013-08-06Novartis AgCompositions comprising an active agent
EP1108439A3 (en)*1999-12-152003-09-10Ing. Erich Pfeiffer GmbHProduct dispenser
US20010029947A1 (en)*1999-12-172001-10-18Steve PaboojianReceptacles to facilitate the extraction of powders
US8336545B2 (en)2000-05-052012-12-25Novartis Pharma AgMethods and systems for operating an aerosol generator
US7971588B2 (en)2000-05-052011-07-05Novartis AgMethods and systems for operating an aerosol generator
US7331339B2 (en)2000-05-052008-02-19Aerogen, Inc.Methods and systems for operating an aerosol generator
US7748377B2 (en)2000-05-052010-07-06Novartis AgMethods and systems for operating an aerosol generator
US7322349B2 (en)2000-05-052008-01-29Aerogen, Inc.Apparatus and methods for the delivery of medicaments to the respiratory system
US7318436B2 (en)2000-05-102008-01-15Innovative Devices, LlcMedicament container with same side airflow inlet and outlet and method of use
US20050056281A1 (en)*2000-05-102005-03-17Snow John M.Medicament container with same side airflow inlet and outlet and method of use
US6923178B2 (en)2000-05-102005-08-02Innovative Devices, Llc.Medicament container with same side airflow inlet and outlet
US6948494B1 (en)2000-05-102005-09-27Innovative Devices, Llc.Medicament container with same side airflow inlet and outlet and method of use
US20020134382A1 (en)*2000-05-102002-09-26Snow John M.Medicament container with same side airflow inlet and outlet and method of use
US7032593B2 (en)2000-08-142006-04-25Advanced Inhalation Research, Inc.Inhalation device and method
US7100600B2 (en)*2001-03-202006-09-05Aerogen, Inc.Fluid filled ampoules and methods for their use in aerosolizers
US7195011B2 (en)2001-03-202007-03-27Aerogen, Inc.Convertible fluid feed system with comformable reservoir and methods
US7032590B2 (en)2001-03-202006-04-25Aerogen, Inc.Fluid filled ampoules and methods for their use in aerosolizers
US8196573B2 (en)2001-03-202012-06-12Novartis AgMethods and systems for operating an aerosol generator
US7278425B2 (en)2001-04-162007-10-09Alkermes, Inc.Inhalation device and method
US7146978B2 (en)2001-04-162006-12-12Advanced Inhalation Research, Inc.Inhalation device and method
US20040154618A1 (en)*2001-04-162004-08-12Advanced Inhalation Research, Inc.Inhalation device and method
US20040154619A1 (en)*2001-04-162004-08-12Advanced Inhalation Research, Inc.Inhalation device and method
US20060283448A1 (en)*2001-04-162006-12-21Advanced Inhalation Research, Inc.Inhalation device and method
US6732732B2 (en)2001-04-162004-05-11Advanced Inhalation Research, Inc.Inhalation device and method
US20040216738A1 (en)*2001-04-162004-11-04Advanced Inhalation Research, Inc.Inhalation device and method
US6978941B2 (en)2001-05-022005-12-27Aerogen, Inc.Base isolated nebulizing device and methods
US7104463B2 (en)2001-05-022006-09-12Aerogen, Inc.Base isolated nebulizing device and methods
US6681768B2 (en)2001-06-222004-01-27Sofotec Gmbh & Co. KgPowder formulation disintegrating system and method for dry powder inhalers
US20050028813A1 (en)*2001-10-052005-02-10Ian HarrisonApparatus for the nasal or oral delivery of a medicament
US7163013B2 (en)*2001-10-052007-01-16Alchemy Healthcare LimitedApparatus for the nasal or oral delivery of a medicament
US7600511B2 (en)2001-11-012009-10-13Novartis Pharma AgApparatus and methods for delivery of medicament to a respiratory system
US10124128B2 (en)*2001-11-142018-11-13Bgp Products Operations GmbhAerosolization apparatus with removable mouthpiece
US20030150454A1 (en)*2001-11-142003-08-14Inhale Therapeutic Systems, Inc.Aerosolization apparatus with removable mouthpiece
US9421166B2 (en)2001-12-192016-08-23Novartis AgPulmonary delivery of aminoglycoside
US20080063606A1 (en)*2001-12-192008-03-13Tarara Thomas EPulmonary delivery of aminoglycoside
US8715623B2 (en)2001-12-192014-05-06Novartis AgPulmonary delivery of aminoglycoside
US7360536B2 (en)2002-01-072008-04-22Aerogen, Inc.Devices and methods for nebulizing fluids for inhalation
US8539944B2 (en)2002-01-072013-09-24Novartis AgDevices and methods for nebulizing fluids for inhalation
US7677467B2 (en)2002-01-072010-03-16Novartis Pharma AgMethods and devices for aerosolizing medicament
US20030131847A1 (en)*2002-01-162003-07-17Fabrizio NiccolaiDevice usable in the treatment of affections of the airways
US6705313B2 (en)*2002-01-162004-03-16Ph&T S.P.A.Device usable in the treatment of affections of the airways
US9700690B2 (en)2002-03-202017-07-11Mannkind CorporationInhalation apparatus
US20050177095A1 (en)*2002-05-142005-08-11Tatsuo TsutsuiPowder chemical feeding device for nasal cavity
US7353823B2 (en)*2002-05-142008-04-08Bioactis LimitedPowder chemical feeding device for nasal cavity
US7771642B2 (en)2002-05-202010-08-10Novartis AgMethods of making an apparatus for providing aerosol for medical treatment
US20040206350A1 (en)*2002-12-192004-10-21Nektar TherapeuticsAerosolization apparatus with non-circular aerosolization chamber
US9138410B2 (en)2003-02-212015-09-22Shin Nippon Biomedical Laboratories, Ltd.Compositions for nasal administration of pharmaceuticals
USRE45404E1 (en)2003-03-272015-03-03Shin Nippon Biomedical Laboratories, Ltd.Powder medicine applicator for nasal cavity
US20090260623A1 (en)*2003-04-092009-10-22Novartis Pharma AgAeorosolization apparatus with air inlet shield
USRE47526E1 (en)2003-04-092019-07-23BGP ProductsAerosolization apparatus with air inlet shield
US8069851B2 (en)2003-04-092011-12-06Novartis AgAeorosolization apparatus with air inlet shield
US20050150492A1 (en)*2003-04-092005-07-14Nektar TherapeuticsAerosolization apparatus with air inlet shield
US8869794B1 (en)*2003-04-092014-10-28Novartis Pharma AgAerosolization apparatus with capsule puncturing member
US7559325B2 (en)2003-04-092009-07-14Novartis Pharma AgAerosolization apparatus with air inlet shield
US8616195B2 (en)2003-07-182013-12-31Novartis AgNebuliser for the production of aerosolized medication
US20050088617A1 (en)*2003-10-272005-04-28Jen-Chuen HsiehMethod and apparatus for visual drive control
US20050153874A1 (en)*2004-01-122005-07-14Mannkind CorporationMethod of reducing serum proinsulin levels in type 2 diabetics
US20050186146A1 (en)*2004-02-122005-08-25Nektar TherapeuticsInterleukin-13 antagonist powders, spray-dried particles, and methods
US8933023B2 (en)2004-03-122015-01-13Biodel Inc.Rapid acting injectable insulin compositions
US20080090753A1 (en)*2004-03-122008-04-17Biodel, Inc.Rapid Acting Injectable Insulin Compositions
US20090192075A1 (en)*2004-03-122009-07-30Biodel Inc.Amylin Formulations
US7290541B2 (en)2004-04-202007-11-06Aerogen, Inc.Aerosol delivery apparatus and method for pressure-assisted breathing systems
US7267121B2 (en)2004-04-202007-09-11Aerogen, Inc.Aerosol delivery apparatus and method for pressure-assisted breathing systems
US7201167B2 (en)2004-04-202007-04-10Aerogen, Inc.Method and composition for the treatment of lung surfactant deficiency or dysfunction
US7946291B2 (en)2004-04-202011-05-24Novartis AgVentilation systems and methods employing aerosol generators
US20070051362A1 (en)*2004-04-232007-03-08Sullivan Timothy RMultiple unit dose drug delivery system
US7723306B2 (en)2004-05-102010-05-25Boehringer Ingelheim Pharma Gmbh & Co. KgSpray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation
US20050250705A1 (en)*2004-05-102005-11-10Boehringer Ingelheim Pharma Gmbh Co. KgSpray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation
US20050250704A1 (en)*2004-05-102005-11-10Boehringer Ingelheim Pharma Gmbh & Co. KgPowder comprising new compositions of oligosaccharides and methods for their preparation
US7611709B2 (en)2004-05-102009-11-03Boehringer Ingelheim Pharma Gmbh And Co. Kg1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
US7727962B2 (en)2004-05-102010-06-01Boehringer Ingelheim Pharma Gmbh & Co. KgPowder comprising new compositions of oligosaccharides and methods for their preparation
US20050255119A1 (en)*2004-05-102005-11-17Boehringer Ingelheim Pharma Gmbh & Co. Kg1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
US8664187B2 (en)2004-06-182014-03-04Novartis AgMethods of treatment of endobronchial infections
US8673360B2 (en)2004-08-102014-03-18Shin Nippon Biomedical Laboratories, Ltd.Compositions that enable rapid-acting and highly absorptive intranasal administration
US9796688B2 (en)2004-08-202017-10-24Mannkind CorporationCatalysis of diketopiperazine synthesis
US9346766B2 (en)2004-08-202016-05-24Mannkind CorporationCatalysis of diketopiperazine synthesis
US10130685B2 (en)2004-08-232018-11-20Mannkind CorporationDiketopiperazine salts for drug delivery and related methods
US9675674B2 (en)2004-08-232017-06-13Mannkind CorporationDiketopiperazine salts for drug delivery and related methods
US10398859B2 (en)*2004-09-152019-09-03Optinose AsNasal delivery devices
US20160095989A1 (en)*2004-09-152016-04-07Optinose AsNasal delivery devices
US8006695B2 (en)2004-11-102011-08-30Cipla LimitedInhaler
US20080105256A1 (en)*2004-11-102008-05-08Cipla LimitedInhaler
WO2006051300A1 (en)2004-11-102006-05-18Cipla LimitedInhaler
US20110183901A1 (en)*2005-03-312011-07-28Mannkind CorporationSuperior Control of Blood Glucose in Diabetes Treatment
US8524735B2 (en)2005-05-182013-09-03Mpex Pharmaceuticals, Inc.Aerosolized fluoroquinolones and uses thereof
US10987357B2 (en)2005-05-182021-04-27Horizon Orphan, LLCAerosolized fluoroquinolones and uses thereof
US8524734B2 (en)2005-05-182013-09-03Mpex Pharmaceuticals, Inc.Aerosolized fluoroquinolones and uses thereof
EP2594272A2 (en)2005-05-182013-05-22Mpex Pharmaceuticals, Inc.Aerosolized fluoroquinolones and uses thereof
US8546423B2 (en)2005-05-182013-10-01Mpex Pharmaceuticals, Inc.Aerosolized fluoroquinolones and uses thereof
US8357696B2 (en)2005-05-182013-01-22Mpex Pharmaceuticals, Inc.Aerosolized fluoroquinolones and uses thereof
US20090090433A1 (en)*2005-05-182009-04-09Symyx Technologies Europe SaApparatus And Method For Storing And Dispensing Material, Especially In Micro Quantities And In Combination With Limited Starting Amounts
US9108211B2 (en)2005-05-252015-08-18Nektar TherapeuticsVibration systems and methods
US10143655B2 (en)2005-09-142018-12-04Mannkind CorporationMethod of drug formulation
US9717689B2 (en)2005-09-142017-08-01Mannkind CorporationMethod of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US9446001B2 (en)2005-09-142016-09-20Mannkind CorporationIncreasing drug affinity for crystalline microparticle surfaces
US9283193B2 (en)2005-09-142016-03-15Mannkind CorporationMethod of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US8084420B2 (en)2005-09-292011-12-27Biodel Inc.Rapid acting and long acting insulin combination formulations
US20070086952A1 (en)*2005-09-292007-04-19Biodel, Inc.Rapid Acting and Prolonged Acting Inhalable Insulin Preparations
US20090137455A1 (en)*2005-09-292009-05-28Biodel Inc.Rapid acting and long acting insulin combination formulations
US10130581B2 (en)2006-02-222018-11-20Mannkind CorporationMethod for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US9241903B2 (en)2006-02-222016-01-26Mannkind CorporationMethod for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
AU2007219498B2 (en)*2006-02-242013-08-22Esteve, VictorDry powder inhaler
CN101389367B (en)*2006-02-242011-10-05阿哈塑料技术有限公司Dry powder inhaler
KR101150000B1 (en)2006-02-242012-06-01아하 쿤스트스트오프테크니크 게엠베하Dry powder inhaler
US20110120463A1 (en)*2006-02-242011-05-26Victor EsteveDry powder inhaler
US8539946B2 (en)2006-02-242013-09-24Eric ZembrodDry powder inhaler
RU2424000C2 (en)*2006-02-242011-07-20ЗЕМБРОД ЭрикDry powder inhaler
WO2007098870A1 (en)*2006-02-242007-09-07Aha Kunststofftechnik GmbhDry powder inhaler
US7713929B2 (en)2006-04-122010-05-11Biodel Inc.Rapid acting and long acting insulin combination formulations
US7718609B2 (en)2006-04-122010-05-18Biodel Inc.Rapid acting and long acting insulin combination formulations
US20080039368A1 (en)*2006-04-122008-02-14Biodel Inc.Rapid acting and long acting insulin combination formulations
US8584669B2 (en)2006-04-132013-11-19Boehringer Ingelheim International GmbhInhaler
US20090194105A1 (en)*2006-04-132009-08-06Jens BesselerInhaler
US7806117B2 (en)*2006-06-072010-10-05Shin Nippon Biomedical Laboratories, Ltd.Peroral powder delivery device
US20070283955A1 (en)*2006-06-072007-12-13Bioactis LimitesPeroral powder delivery device
US20090320838A1 (en)*2006-06-162009-12-31Cipla LimitedDry powder inhaler
US8522775B2 (en)*2006-06-162013-09-03Cipla LimitedDry powder inhaler
US10195139B2 (en)2006-12-262019-02-05Shin Nippon Biomedical Laboratories, Ltd.Preparation for transnasal application
US8377009B2 (en)2007-01-092013-02-19Mystic Pharmaceuticals, Inc.Intranasal cartridge devices
US20080177246A1 (en)*2007-01-092008-07-24First City TowerIntranasal Cartridge Devices
US20080248999A1 (en)*2007-04-042008-10-09Biodel Inc.Amylin formulations
US20100288275A1 (en)*2007-04-052010-11-18Optinose AsNasal administration
US10722667B2 (en)2007-04-052020-07-28Optinose AsNasal administration
US8875704B2 (en)2007-04-052014-11-04Optinose AsNasal administration
US9649456B2 (en)*2007-04-052017-05-16Optinose AsNasal administration
US7669597B2 (en)2007-05-162010-03-02Mystic Pharmaceuticals, Inc.Combination unit dose dispensing containers
US9248076B2 (en)2007-05-162016-02-02Mystic Pharmaceuticals, Inc.Dose dispensing containers
US8683995B2 (en)2007-05-162014-04-01Mystic Pharmaceuticals, Inc.Dose dispensing containers
US9592354B2 (en)2007-05-162017-03-14Mystic Pharmaceuticals, Inc.Combination unit dose dispensing containers
US8496002B2 (en)2007-06-122013-07-30Civitas Therapeutics, Inc.Powder inhaler devices
US20090025721A1 (en)*2007-06-122009-01-29Alkermes, Inc.Powder inhaler devices
US20100313886A1 (en)*2007-08-012010-12-16Herbert WachtelInhaler
CN101815552B (en)*2007-08-012013-03-06贝林格尔.英格海姆国际有限公司Inhaler
US8919342B2 (en)2007-08-012014-12-30Boehringer Ingelheim International GmbhInhaler
US7963089B2 (en)2007-09-142011-06-21Mystic Pharmaceuticals, Inc.Deep draw container forming method
US20090071108A1 (en)*2007-09-142009-03-19Mystic Pharmaceuticals, Inc.Deep draw container forming method
US8785396B2 (en)2007-10-242014-07-22Mannkind CorporationMethod and composition for treating migraines
US20100287884A1 (en)*2007-10-252010-11-18Sangita SeshadriPowder conditioning of unit dose drug packages
US20090175840A1 (en)*2008-01-042009-07-09Biodel, Inc.Insulin formulations for insulin release as a function of tissue glucose levels
US20110056488A1 (en)*2008-01-242011-03-10Vectura Delivery Devices LimitedInhaler
US9125998B2 (en)2008-01-242015-09-08Vectura Delivery Devices LimitedInhaler
US10016582B2 (en)2008-02-072018-07-10University Of Washington Through Its Center For CommercializationCircumferential aerosol device
US20090241949A1 (en)*2008-03-272009-10-01Smutney Chad CDry powder inhalation system
US10751488B2 (en)2008-06-132020-08-25Mannkind CorporationDry powder inhaler and system for drug delivery
US10342938B2 (en)2008-06-132019-07-09Mannkind CorporationDry powder drug delivery system
US9339615B2 (en)2008-06-132016-05-17Mannkind CorporationDry powder inhaler and system for drug delivery
US9192675B2 (en)2008-06-132015-11-24Mankind CorporationDry powder inhaler and system for drug delivery
US9446133B2 (en)2008-06-132016-09-20Mannkind CorporationDry powder inhaler and system for drug delivery
US9511198B2 (en)2008-06-132016-12-06Mannkind CorporationDry powder inhaler and system for drug delivery
US10201672B2 (en)2008-06-132019-02-12Mannkind CorporationDry powder inhaler and system for drug delivery
US9662461B2 (en)2008-06-132017-05-30Mannkind CorporationDry powder drug delivery system and methods
US9364619B2 (en)2008-06-202016-06-14Mannkind CorporationInteractive apparatus and method for real-time profiling of inhalation efforts
US10675421B2 (en)2008-06-202020-06-09Mannkind CorporationInteractive apparatus and method for real-time profiling of inhalation efforts
US8623817B2 (en)2008-08-112014-01-07Mannkind CorporationMethod of treating diabetes type 2 by administering ultrarapid acting insulin
US9943571B2 (en)2008-08-112018-04-17Mannkind CorporationUse of ultrarapid acting insulin
US20110171312A1 (en)*2008-09-192011-07-14Nektar TherapeuticsModified therapeutic peptides, methods of their preparation and use
US9682153B2 (en)2008-09-192017-06-20Nektar TherapeuticsPolymer conjugates of therapeutic peptides
US9717738B2 (en)2008-10-072017-08-01Horizon Orphan LlcAerosol fluoroquinolone formulations for improved pharmacokinetics
US11020481B2 (en)2008-10-072021-06-01Horizon Orphan LlcTopical use of levofloxacin for reducing lung inflammation
US9326936B2 (en)2008-10-072016-05-03Raptor Pharmaceuticals, Inc.Aerosol fluoroquinolone formulations for improved pharmacokinetics
US8629139B2 (en)2008-10-072014-01-14Mpex Pharmaceuticals, Inc.Topical use of Levofloxacin for reducing lung inflammation
US10149854B2 (en)2008-10-072018-12-11Horizon Orphan LlcAerosol fluoroquinolone formulations for improved pharmacokinetics
US8815838B2 (en)2008-10-072014-08-26David C. GriffithAerosol fluoroquinolone formulations for improved pharmacokinetics
US10722519B2 (en)2008-10-072020-07-28Horizon Orphan LlcAerosol fluoroquinolone formulations for improved pharmacokinetics
US9220687B2 (en)2008-12-292015-12-29Mannkind CorporationSubstituted diketopiperazine analogs for use as drug delivery agents
US9655850B2 (en)2008-12-292017-05-23Mannkind CorporationSubstituted diketopiperazine analogs for use as drug delivery agents
US10172850B2 (en)2008-12-292019-01-08Mannkind CorporationSubstituted diketopiperazine analogs for use as drug delivery agents
US9060927B2 (en)2009-03-032015-06-23Biodel Inc.Insulin formulations for rapid uptake
US9983108B2 (en)2009-03-112018-05-29Mannkind CorporationApparatus, system and method for measuring resistance of an inhaler
US20110033544A1 (en)*2009-05-152011-02-10Shin Nippon Biomedical Laboratories, Ltd.Intranasal pharmaceutical compositions with improved pharmacokinetcs
US9101539B2 (en)2009-05-152015-08-11Shin Nippon Biomedical Laboratories, Ltd.Intranasal pharmaceutical compositions with improved pharmacokinetics
US9630930B2 (en)2009-06-122017-04-25Mannkind CorporationDiketopiperazine microparticles with defined specific surface areas
US20110045088A1 (en)*2009-07-312011-02-24Shin Nippon Biomedical Laboratories, Ltd.Intranasal granisetron and nasal applicator
US8827946B2 (en)2009-07-312014-09-09Shin Nippon Biomedical Laboratories, Ltd.Intranasal granisetron and nasal applicator
US10231975B2 (en)2009-09-042019-03-19Horizon Orphan LlcUse of aerosolized levofloxacin for treating cystic fibrosis
US9700564B2 (en)2009-09-042017-07-11Horizon Orphan LlcUse of aerosolized levofloxacin for treating cystic fibrosis
US10792289B2 (en)2009-09-042020-10-06Horizon Orphan LlcUse of aerosolized levofloxacin for treating cystic fibrosis
US9706944B2 (en)2009-11-032017-07-18Mannkind CorporationApparatus and method for simulating inhalation efforts
US9492625B2 (en)2009-11-122016-11-15Stc.UnmDry powder inhaler with flutter dispersion member
WO2011163518A1 (en)2010-06-242011-12-29Gilead Sciences, Inc.Pyrazolo [1, 5 -a] pyrimidines as antiviral agents
EP3012258A1 (en)2010-06-242016-04-27Gilead Sciences, Inc.Pyrazolo[1,5-a]pyrimidines and -triazines as antiviral agents
WO2012012776A1 (en)2010-07-222012-01-26Gilead Sciences, Inc.Methods and compounds for treating paramyxoviridae virus infections
WO2012037038A1 (en)2010-09-132012-03-22Gilead Sciences, Inc.2' -fluoro substituted carba-nucleoside analogs for antiviral treatment
US8561609B2 (en)2010-12-072013-10-22Respira Therapeutics, Inc.Dry powder inhaler
US8651104B2 (en)2010-12-072014-02-18Respira Therapeutics, Inc.Bead-containing dry powder inhaler
WO2012106382A1 (en)2011-01-312012-08-09Genoa Pharmaceuticals, Inc.Aerosol pirfenidone and pyridone analog compounds and uses thereof
EP4059499A1 (en)2011-01-312022-09-21Avalyn Pharma Inc.Aerosol pirfenidone and pyridone analog compounds and uses thereof
US10507295B2 (en)2011-03-032019-12-17Impel Neuropharma, Inc.Nasal drug delivery device
US11730903B2 (en)2011-03-032023-08-22Impel Pharmaceuticals Inc.Nasal drug delivery device
US9550036B2 (en)2011-03-032017-01-24Impel Neuropharma Inc.Nasal drug delivery device
US10625034B2 (en)2011-04-012020-04-21Mannkind CorporationBlister package for pharmaceutical cartridges
US10940278B2 (en)2011-05-092021-03-09Impel Neuropharma, Inc.Nozzles for nasal drug delivery
US9919117B2 (en)2011-05-092018-03-20Impel Neuropharma Inc.Nozzles for nasal drug delivery
US11007332B2 (en)2011-05-092021-05-18Impel Neuropharma, Inc.Nozzles for nasal drug delivery
US11890412B2 (en)2011-05-092024-02-06Impel Pharmaceuticals Inc.Nozzles for nasal drug delivery
US9364436B2 (en)2011-06-172016-06-14Mannkind CorporationHigh capacity diketopiperazine microparticles and methods
US10130709B2 (en)2011-06-172018-11-20Mannkind CorporationHigh capacity diketopiperazine microparticles and methods
WO2013016784A1 (en)2011-08-042013-02-07Victor EsteveDry powder inhaler
WO2013016787A1 (en)2011-08-042013-02-07Victor EstevePowder inhaler
US9233159B2 (en)2011-10-242016-01-12Mannkind CorporationMethods and compositions for treating pain
US10258664B2 (en)2011-10-242019-04-16Mannkind CorporationMethods and compositions for treating pain
US9610351B2 (en)2011-10-242017-04-04Mannkind CorporationMethods and compositions for treating pain
US11471623B2 (en)2012-02-212022-10-18Respira Therapeutics, Inc.Powder dispersion methods and devices
EP3351552A1 (en)2012-03-132018-07-25Gilead Sciences, Inc.2'- substituted carba-nucleoside analogs for antiviral treatment
MD4496C1 (en)*2012-03-132018-02-28Gilead Sciences, Inc.2'-Substituted carba-nucleoside analogs for antiviral treatment
EP3932931A1 (en)2012-03-132022-01-05Gilead Sciences, Inc.A nebulizer comprising a pharmaceutical composition comprising 2'- substituted carba-nucleoside analogs for antiviral treatment
EP3210993A1 (en)2012-03-132017-08-30Gilead Sciences, Inc.2'- substituted carba-nucleoside analogs for antiviral treatment
WO2013158776A1 (en)2012-04-172013-10-24Gilead Sciences, Inc.Compounds and methods for antiviral treatment
US20130327327A1 (en)*2012-06-062013-12-12Aerodesigns, Inc.Aerosol dispenser with replaceable cartridge
US9845187B2 (en)*2012-06-062017-12-19Aerodesigns, Inc.Aerosol dispenser with replaceable cartridge
US10441733B2 (en)2012-06-252019-10-15Respira Therapeutics, Inc.Powder dispersion devices and methods
US9802012B2 (en)2012-07-122017-10-31Mannkind CorporationDry powder drug delivery system and methods
US10159644B2 (en)2012-10-262018-12-25Mannkind CorporationInhalable vaccine compositions and methods
US9757395B2 (en)2012-12-202017-09-12Otitopic Inc.Dry powder inhaler and methods of use
US12329899B2 (en)2012-12-202025-06-17Aspeya US Inc.Dry powder inhaler and methods of use
US9757529B2 (en)2012-12-202017-09-12Otitopic Inc.Dry powder inhaler and methods of use
US10421729B2 (en)2013-03-152019-09-24Mannkind CorporationMicrocrystalline diketopiperazine compositions and methods
US10537692B2 (en)2013-04-282020-01-21Impel Neuropharma, Inc.Medical unit dose container
US11191910B2 (en)2013-04-282021-12-07Impel Neuropharma, Inc.Medical unit dose container
US10149823B2 (en)2013-04-302018-12-11Otitopic Inc.Dry powder formulations and methods of use
US11865210B2 (en)2013-04-302024-01-09Vectura Inc.Dry powder formulations and methods of use
US11819569B2 (en)2013-04-302023-11-21Vectura Inc.Treating inflammation with inhaled aspirin
US10207065B2 (en)2013-07-122019-02-19John H. SilvaMouthpiece for inhalers
WO2015006838A1 (en)2013-07-162015-01-22Victor EstevePowder inhaler
US9925144B2 (en)2013-07-182018-03-27Mannkind CorporationHeat-stable dry powder pharmaceutical compositions and methods
EP3782604A1 (en)2013-07-312021-02-24Windward Pharma, Inc.Aerosol tyrosine kinase inhibitor compounds and uses thereof
US11446127B2 (en)2013-08-052022-09-20Mannkind CorporationInsufflation apparatus and methods
EP4122932A1 (en)2013-11-112023-01-25Gilead Sciences, Inc.Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections
EP3505173A1 (en)2013-11-112019-07-03Gilead Sciences, Inc.Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections
US10028966B2 (en)2014-01-102018-07-24Avalyn Pharma Inc.Aerosol pirfenidone and pyridone analog compounds and uses thereof
EP4491180A1 (en)2014-01-102025-01-15Avalyn Pharma Inc.Aerosol pirfenidone and pyridone analog compounds and uses thereof
US9993488B2 (en)2014-02-202018-06-12Otitopic Inc.Dry powder formulations for inhalation
USD755367S1 (en)2014-03-102016-05-03Civitas Therapeutics, Inc.Indicator for an inhaler
USD752734S1 (en)2014-03-102016-03-29Civitas Therapeutics, Inc.Inhaler grip
USD752204S1 (en)2014-03-102016-03-22Civitas Therapeutics, Inc.Indicator for an inhaler
US10307464B2 (en)2014-03-282019-06-04Mannkind CorporationUse of ultrarapid acting insulin
USD748242S1 (en)2014-07-112016-01-26H. Stuart CampbellInhaler mouthpiece
WO2016018697A1 (en)2014-07-282016-02-04Gilead Sciences, Inc.Thieno [3,2-d] pyrimidine, furo [3,2,d] pyrimidine, and pyrrolo [3,2-d] pyrimidines useful for treating respiratory syncitial virus infections
EP3693367A1 (en)2014-07-282020-08-12Gilead Sciences, Inc.Thieno [3,2-d]pyrimidines, furo [3,2,d]pyrimidines and pyrrolo [3,2-d]pyrimidines useful for treating respiratory syncitial virus infections
EP4023650A1 (en)2014-07-282022-07-06Gilead Sciences, Inc.4'-substituted-furo[3,2-d]pyrimidine and -pyrrolo[3,2- d]pyrimidine derivatives useful for treating respiratory syncitial virus infections
EP3738969A1 (en)2014-08-212020-11-18Gilead Sciences, Inc.2'-chloro aminopyrimidinone and pyrimidine dione nucleosides for use in treating pneumovirinae virus infections
US10561806B2 (en)2014-10-022020-02-18Mannkind CorporationMouthpiece cover for an inhaler
US20170006917A1 (en)*2015-07-072017-01-12Altria Client Services Inc.E-vapor device including capsule containing pre-vapor formulation
US10874139B2 (en)*2015-07-072020-12-29Altria Client Services LlcE-vapor device including capsule containing pre-vapor formulation
US11266799B2 (en)2015-09-102022-03-08Impel Neuropharma, Inc.In-line nasal delivery device
WO2017094027A1 (en)*2015-12-012017-06-08Cipla LimitedNasal spray assembly
US10940274B2 (en)2015-12-012021-03-09Cipla LimitedNasal spray assembly
US11273268B2 (en)*2016-07-072022-03-15Philip Morris Products S.A.Nicotine inhaler system
US12102754B2 (en)2017-09-262024-10-01Shin Nippon Biomedical Laboratories, Ltd.Intranasal delivery devices
US11744967B2 (en)2017-09-262023-09-05Shin Nippon Biomedical Laboratories, Ltd.Intranasal delivery devices
US20200289769A1 (en)*2017-10-122020-09-17Aptar France SasDevice for dispensing a fluid product
US11672926B2 (en)*2017-10-122023-06-13Aptar France SasDevice for dispensing a fluid product
US11571532B2 (en)2017-11-212023-02-07Impel Pharmaceuticals Inc.Intranasal device with dip tube
US11878110B2 (en)2017-11-212024-01-23Impel Pharmaceuticals Inc.Intranasal device with inlet interface
CN111372635A (en)*2017-11-212020-07-03英倍尔药业股份有限公司Intranasal device with access port
US11395887B2 (en)2017-11-212022-07-26Impel Pharmaceuticals Inc.Intranasal device with inlet interface
CN111372635B (en)*2017-11-212022-08-16英倍尔制药公司Intranasal device with access port
US11278492B2 (en)2018-01-052022-03-22Impel Neuropharma, Inc.Intranasal delivery of olanzapine by precision olfactory device
US11185497B2 (en)2018-01-052021-11-30Impel Neuropharma, Inc.Intranasal delivery of dihydroergotamine by precision olfactory device
US11752100B2 (en)2018-01-052023-09-12Impel Pharmaceuticals Inc.Intranasal delivery of olanzapine by precision olfactory device
US11690819B2 (en)2018-07-192023-07-04Impel Pharmaceuticals Inc.Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's disease
US11517548B2 (en)2018-07-192022-12-06Impel Pharmaceuticals Inc.Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's Disease
CN109078245A (en)*2018-10-112018-12-25上海博极给药医药科技有限公司A kind of double-capsule type powder inhaler
US11759585B2 (en)2019-01-032023-09-19Impel Pharmaceuticals Inc.Nasal drug delivery device with detachable nozzle
US11878109B2 (en)2019-05-172024-01-23Impel Pharmaceuticals Inc.Single-use nasal delivery device
WO2021130638A1 (en)2019-12-242021-07-01Carna Biosciences, Inc.Diacylglycerol kinase modulating compounds
EP4445902A2 (en)2019-12-242024-10-16Carna Biosciences, Inc.Diacylglycerol kinase modulating compounds
WO2021168008A1 (en)2020-02-182021-08-26Gilead Sciences, Inc.A 5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2-cyano-3,4-dihydroxytetrahydrofurane derivative as antiviral agent
WO2021168038A1 (en)2020-02-182021-08-26Gilead Sciences, Inc.Antiviral compounds
WO2021167882A1 (en)2020-02-182021-08-26Gilead Sciences, Inc.Antiviral compounds
WO2021168004A1 (en)2020-02-182021-08-26Gilead Sciences, Inc.Antiviral compounds
WO2021222522A1 (en)2020-05-012021-11-04Gilead Sciences, Inc.Cd73 inhibiting 2,4-dioxopyrimidine compounds
WO2022240897A1 (en)2021-05-102022-11-17Sepelo Therapeutics, LlcPharmaceutical composition comprising delafloxacin for administration into the lung
WO2022271659A1 (en)2021-06-232022-12-29Gilead Sciences, Inc.Diacylglyercol kinase modulating compounds
WO2022271684A1 (en)2021-06-232022-12-29Gilead Sciences, Inc.Diacylglyercol kinase modulating compounds
WO2022271650A1 (en)2021-06-232022-12-29Gilead Sciences, Inc.Diacylglyercol kinase modulating compounds
WO2022271677A1 (en)2021-06-232022-12-29Gilead Sciences, Inc.Diacylglyercol kinase modulating compounds
WO2023028364A1 (en)2021-08-272023-03-02Sepelo Therapeutics, LlcTargeted compositions and uses therof
WO2023077030A1 (en)2021-10-292023-05-04Gilead Sciences, Inc.Cd73 compounds
WO2025120297A1 (en)*2023-12-062025-06-12Industrial Design Consultancy LtdPowder dispensers

Also Published As

Publication numberPublication date
GB1436813A (en)1976-05-26
DE7411543U (en)1976-02-05
DE2415961A1 (en)1974-10-17
FR2224175B1 (en)1978-04-14
BE813143A (en)1974-07-31
FR2224175A1 (en)1974-10-31
CH569486A5 (en)1975-11-28
JPS5048782A (en)1975-05-01

Similar Documents

PublicationPublication DateTitle
US3906950A (en)Inhaling device for powdered medicaments
US3949751A (en)Method and device for dispensing medicament to the body
US1848711A (en)Hypodermic sybinckb
US4295828A (en)Ejector holder for syringe-type cartridge
DE69635167T2 (en) SUBCUTANEOUS JET INJECTOR
US4137914A (en)Aerosol inhalation device
US7284553B2 (en)Powder inhaler comprising a chamber for a capsule for taking up a non-returnable capsule being filled with an active ingredient
TWI288649B (en)Powdery medicine dispensing device for nasal cavity
ES2288870T3 (en) RETRACTILE DENTAL SYRINGE.
US8708973B2 (en)Medicament delivery device powered by volute spring
AU726983B2 (en)Syringe with retractable needle assembly
US3757781A (en)Tool for administering pills to animals
FI88678C (en) Inhaler
US6077252A (en)Single or multiple dose syringe
US3080866A (en)Hypodermic needle
US3724460A (en)Disposable cartridge for admixing two components of injectable medicament
US20030093032A1 (en)Intradermal delivery device and method
AR043668A1 (en) SPRING RETAINING FOR SYRINGE
AU7263487A (en)Mixing and discharge capsule
US3182660A (en)Hypodermic syringe with spring biassed piston
JPS5841067B2 (en) Fun matsuzaiyoukiyuuniyuki
US3066671A (en)Disposable additive container
EP0154345A2 (en)Cartridge with plug opening mechanism
JP2019506968A (en) Safety needle
US2737949A (en)Disposable cartridge for hypodermic syringe

[8]ページ先頭

©2009-2025 Movatter.jp